state

;

Letter asking Gov. Newsom to sign CA SB1023 to expand access to all forms of PrEP

Sep 3, 2026

We strongly believe that access to all forms of PrEP is essential to ending HIV in California. Nearly 5,000 Californians are diagnosed with HIV each year, and persistent disparities underscore the need to ensure access to the full range of HIV prevention options. Patients should be able to choose the PrEP option that works best for them without unnecessary insurance or administrative barriers. For these reasons, we respectfully urge you to sign Senate Bill 1023 into law.

read more

NAIC consumer reps letter to MS Comm. Chaney on preventive services

Jul 17, 2026

The undersigned Consumer Representatives to the National Association of Insurance Commissioners (NAIC) write to express our deep concern regarding your recent public statements indicating that you do not intend to enforce the Affordable Care Act’s preventive services requirements with respect to coverage of pre-exposure prophylaxis (PrEP) for HIV prevention. Under federal law, which was recently upheld by the U.S. Supreme Court in Kennedy v. Braidwood Management, Inc., insurers must cover without cost sharing evidence-based preventive services that receive a grade “A” and “B” from the U.S. Preventive Services Task Force (USPSTF). Also, under federal law, it is the responsibility of state regulators to ensure that insurers are in compliance, and that health coverage is administered fairly and consistently.

read more

Letter to Delaware Governor Meyer in Support of Preserving PrEP and PEP Access

Jul 7, 2026

The HIV+Hepatitis Policy Institute is a national organization promoting quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. We write in strong support of House Substitute 1 for House Bill 200 and respectfully urge you to sign this critical legislation into law. This bill protects Delawareans at risk of HIV by preserving access to highly effective pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) medications and related services without cost-sharing, prior authorization, or step therapy barriers.

read more

Complaint letter to Mississippi insurance commissioner on Blue Cross Blue Shield of Mississippi PrEP & HIV treatment coverage Restrictions

Jun 1, 2026

We are submitting this formal complaint against Blue Cross Blue Shield of Mississippi (BCBSMS) regarding certain formularies offered on the individual and fully insured markets in Mississippi. First, BCBSMS is violating federal preventive health coverage requirements by covering only one of four pre-exposure prophylaxis (PrEP) medications to prevent HIV. Second, BCBSMS’ medical policy deeming long-acting injectables for the treatment of HIV “not medically necessary” does not allow for a meaningful formulary exceptions process as required by federal Essential Health Benefit (EHB) regulations.

read more

Search

Categories

Tags

340B ACA Appropriations Biden administration CDC CMS co-pay accumulators Congress copay accumulator Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men Hepatitis Hepatitis B hepatitis C Hepatitis Prevention HHS HIV HIV Prevention Insurers Medicaid medicare Medicare Part D NAIC NIH PBM PBMs PrEP Prescription Drugs prior authorization Private Insurance private insurers Ryan White Program state STDs Syringe services Testing transparency Treatment Trump administration women

Recent Testimony, Letters, Comments

Pin It on Pinterest